$UnitedHealth(UNH)$
Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com).
Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business.
The Conviction List is reserved for Goldman’s highest-conviction Buy ideas.
$Meta Platforms, Inc.(META)$
$Microsoft(MSFT)$
$Apple(AAPL)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments
$BABA-W(09988)$
$MEITUAN-W(03690)$
$CATL(03750)$
$Sea Ltd(SE)$
LOAD UP UNITED HEALTH CHEAP
Great article, would you like to share it?